Log in
Language
Resource center
Contact app support
Legal
Home
CPHI Online
Sign up to our Newsletter
Innovent Biologics / Altruist Biologics
Exhibitors
Products
Sessions
Information
.
Contact details
United States
Products
TYVYT®: Sintilimab Injection
BYVASDA®: Bevacizumab Injection
HALPRYZA®: Rituximab Injection
SULINNO®: Adalimumab Injection
SINTBILO® :Tafolecimab Injection
Sessions
Unprecedented Post-Approval Production Cell Line Change of a Bevacizumab Biosimilar with the NMPA
Wednesday, October 25, 2023 12:45 PM to 1:15 PM
BioProduction Content - 3C49
Sun Chau Siu · Altruist Biologics
Log in
See all the content and easy-to-use features by logging in or registering!
Log in
Continue as a guest